Services

Our services are centred around intellectual property that can be registered. We protect innovation, design, and branding across all sectors of industry, and at all stages in the supply chain.

For each IP right we offer services covering strategic advice, pre-registration searches, registrations and renewals, oppositions and dispute resolution. We handle work throughout the world, working with local colleagues in over 100 countries.

Sectors

Our attorneys specialise in one or more sectors of industry, which enables them to provide quality advice with a commercial focus.

Our patent specialists have detailed understanding of the background technology, which ensures that your patent applications are prepared with the correct scope, reducing the likelihood of challenges from third parties and objections from the patent office.

They also advise whether other forms of protection would be more appropriate. Our brand specialists work with brand managers for leading brands and their advice is commercially focussed making sure that you get the best value from your budget.

12th Dec 2023

European Patent Office will accelerate oppositions where an infringement or revocation action is instituted before the Unified Patent Court or another court

In the November 2023 issue of the European Patent Office (EPO) Official Journal, the EPO has confirmed that it will accelerate “parallel opposition proceedings” in the interest of “legal certainty and procedural efficiency, as well as high quality and uniformity in the European patent system”.

11th Dec 2023

How a Recent Judgment in the UK Regarding Patenting AI-based Inventions May Influence IP Strategy for AI Innovators

There is no hiding from the fact that artificial intelligence (AI) has well and truly burst onto the scene. Although research into AI has been going on for decades, it is only within the last few years that we have witnessed an explosion of AI applications with profound implications.

20th Nov 2023

Gilead Sciences v NuCana: Lessons for parallel UK and EPO proceedings

In a UK Patents Court case decided earlier this year, Gilead Sciences v NuCana, Gilead sought revocation of the UK designations of two of NuCana’s European patents, EP 2955190B1 and EP 3904365B1, from the same family. These patents covered NuCana’s anti-cancer drug acelarin. NuCana counterclaimed that their patents were infringed by Gilead’s anti-viral products containing the compound sofosbuvir.

9th Nov 2023

Intellectual Property Rights Improve Funding and Exit Performance of European Start-ups

A new joint study by the European Patent Office (EPO) and European Union Intellectual Property Office (EUIPO) shows that start-ups which file applications for registered Intellectual Property Rights (IPR) – including patents, trademarks, and designs – demonstrate a higher likelihood of securing funding from Venture Capital firms (VCs) and achieving favourable exit outcomes for their investors.

Saved Staff
Staff member

Remove all

Saved profiles
Call +44 (0)20 7242 0901
Call +44 (0)1223 360 350
Call +49 (0) 89 206054 267
Call +(00) 31 70 800 2162

    X

    Register for notifications
    Enter your email address here to receive our monthly bulletin of IP news and developments.

    "*" indicates required fields

    Sector*
    I confirm that I have read Reddie & Grose's privacy notice and consent to my personal information being collected*
    Please read our privacy notice.